Stay updated on Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T04:36:29.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new information about a study on gastric cancer, specifically mentioning the drug Capecitabine and the study's revision number. The previous detailed description of the study's purpose and criteria has been removed.
    Difference
    9%
    Check dated 2025-04-16T14:39:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:26:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:23:34.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:38:25.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-02-17T14:43:13.000Z thumbnail image

Stay in the know with updates to Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.